What is Dengue Fever?

Symptoms of the disease are a high fever that begins within 4 to 7 days of being bitten by an infected mosquito, a severe headache, pain behind the eye, severe joint and muscle pain, nausea and vomiting, a rash and also an inability to clot blood properly due to low platelet count from internal bleeding.

Dengue fever is a vector-borne disease. A vector-borne disease is one in which a pathogenic microorganism is transmitted from one individual to another by a arthropod or other agent like an animal. Arthropods are insects, spiders, centipedes, shrimp, and crayfish.

Symptoms of the disease are a high fever that begins within 4 to 7 days of being bitten by an infected mosquito, a severe headache, pain behind the eye, severe joint and muscle pain, nausea and vomiting, a rash and also an inability to clot blood properly due to low platelet count from internal bleeding. The rash appears over most of the body approximately 3 or 4 days after the fever began. The rash then subsides after 1 or 2 days. A second rash may appear a few days after the first one disappears.

The diagnosis for dengue fever is made using two blood tests done 2 to 3 weeks apart. When there is an epidemic of dengue fever, there is usually no time for blood tests and physicians will make the diagnosis solely on presenting symptoms.

Recovery from dengue fever is about 2 weeks from onset. The patient is usually told to get plenty of bed rest, drink lots of fluids and take medicine to reduce the fever. The Center for Disease Control has advised individuals to not take aspirin for fever reduction, and that acetaminophen or other over-the-counter pain-reducing medicines are safer for most individuals to take.

Severe forms of dengue involve symptoms of shock, coma, and possibly death. It is imperative that if these symptoms should start to show that the individual be taken to an emergency room immediately. In the emergency room they will use electrolyte replacement therapy to save the individual's life.

Measles Disease Parsites must be cleared first before using the preventative diethylcarbamazine. The treatment for filariasis is a high-dose of ivermectin (200 micrograms/kg) for lymphatic filariasis; ivermectin (150 micrograms/kg every 6 months for 1 year, and then annually for at least 5 years) for onchoceriasis; diethylcarbamazine (75 mg/kg total, but you must start out with 1/4 tablet per day and then you must slowly work up to 3 tablets 3 times a day for over a period of 3 weeks to avoid anaphylactic shock from destruction of the worms. Another treatment is ivermectin (400 microgram/kg) as a single dose for loiasis. Measles Disease

The best way to prevent the spread of dengue fever is to eliminate the risks that mosquitoes pose by using insect repellent that contain DEET, picaridin, or oil of lemon eucalyptus. Use protective clothing that includes long sleeves, long pants, socks and shoes. The Aedes mosquitoes usually bite during the day; it is imperative that you are especially careful to avoid mosquitoes during the day. You can also keep all unscreened windows and doors closed, spray screens with insect repellent, use a bedding net while sleeping and to eliminate all areas that mosquitoes can use to breed in such as standing water, containers with standing water such as birdbaths and discarded tires.

The majority of individuals who contract dengue fever recover completely within 2 weeks of onset. Depression or extreme tiredness may set in and last for a few weeks or months after onset of the disease.

Complications from severe cases include hemorrhagic fever, dengue shock syndrome, vascular (blood vessel) damage, liver damage - all of which can be life threatening.

Scientists are trying to develop vaccines for dengue fever. Research is being done to prevent dengue viruses from reproducing inside mosquitoes.

Dengue fever is a global threat. Scientist still do not know how the virus infects the cells and cause the disease.

New research is currently being done to try to understand how the virus interacts with humans.

Tropical Disease Dangers!

09/02/2010
Dr. Reese Halter: Stupendous Tropical Rainforests Offer Medicine and Fight Global Warming
Tropical forests are felled at approximately 55,000 square miles a year. This is equivalent to the area of Switzerland and the Netherlands combined -- the size of a football field every second.

Dr. Reese Halter: Stupendous Tropical Rainforests Offer Medicine and Fight Global Warming

09/04/2010
Novartis and collaborators discover novel antimalarial drug candidate
Novartis announced that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.

Novartis and collaborators discover novel antimalarial drug candidate

09/02/2010
Novartis Malaria Drug May Yield First New Treatment in 30 Years
An experimental Novartis AG medicine that killed drug-resistant malaria in laboratory studies may become the first new class of treatment against the disease in 30 years, researchers said.

Novartis Malaria Drug May Yield First New Treatment in 30 Years

09/04/2010
Compound Cleared Malaria Parasites Quickly In Mice
A chemical that rid mice of malaria-causing parasites after a single oral dose may eventually become a new malaria drug if further tests in animals and people uphold the promise of early findings. The compound, NITD609, was developed by an international team of researchers including Elizabeth A. Winzeler, Ph.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID), part ...

Compound Cleared Malaria Parasites Quickly In Mice

08/31/2010
How Disease-Causing Parasite Gets Around Human Innate Immunity
Trypanosomes are parasites responsible for many human and animal diseases, primarily in tropical climates. One disease these parasites cause, African sleeping sickness, results from the bite of infected tsetse flies, putting over 60 million Africans at risk in 36 sub-Saharan countries. The recent 1998-2001 sleeping sickness epidemics in South Sudan, Angola, Democratic Republic of Congo and ...

How Disease-Causing Parasite Gets Around Human Innate Immunity

09/03/2010
News From The Journal Of Clinical Investigation: Sept. 1, 2010
INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriya Tsuji, at the Aaron Diamond AIDS Research Center, New York, has now designed a new vaccine that provides protection from malaria in mice. The team ...

News From The Journal Of Clinical Investigation: Sept. 1, 2010

09/02/2010
New Potential Malaria Treatment Identified
A newly identified compound kills the malaria parasite well before it creates major health problems within an infected person, a new study finds. It might one day serve as a new drug to treat the infectious disease.

New Potential Malaria Treatment Identified